Tikvah Therapeutics

Tikvah Therapeutics was a specialty biopharmaceutical company dedicated to developing and commercializing late-stage clinical assets for central nervous system (CNS) disorders. Headquartered in Atlanta, Georgia, the company focused on addressing unmet medical needs in conditions such as Parkinson's disease, attention deficit hyperactivity disorder (ADHD), and sleep-related ailments. Tikvah's business model involved licensing promising compounds and advancing them through clinical trials, with a pipeline that included treatments for sialorrhea and multiple sclerosis. The company operated as a portfolio entity of Paramount BioSciences, a global drug development firm. Although it made significant strides in Phase 2 clinical testing, Tikvah Therapeutics is no longer active in the biotechnology sector.